360 related articles for article (PubMed ID: 17415999)
1. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
Cao Q; Feng YJ
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells.
Cai G; Wang J; Xin X; Ke Z; Luo J
Int J Oncol; 2007 Sep; 31(3):657-62. PubMed ID: 17671694
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells.
Cao Q; Lu X; Feng YJ
Cell Res; 2006 Jul; 16(7):671-7. PubMed ID: 16788573
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer.
Cho YJ; Yoon J; Ko YS; Kim SY; Cho SJ; Kim WH; Park JW; Youn HD; Kim JH; Lee BL
APMIS; 2010 Oct; 118(10):782-90. PubMed ID: 20854473
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.
Sun J; Yan P; Chen Y; Chen Y; Yang J; Xu G; Mao H; Qiu Y
Diagn Pathol; 2015 Jun; 10():72. PubMed ID: 26088648
[TBL] [Abstract][Full Text] [Related]
8. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
[TBL] [Abstract][Full Text] [Related]
9. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.
Atkins RJ; Dimou J; Paradiso L; Morokoff AP; Kaye AH; Drummond KJ; Hovens CM
J Clin Neurosci; 2012 Nov; 19(11):1558-63. PubMed ID: 22999562
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.
Soda M; Willert K; Kaushansky K; Geddis AE
Cell Signal; 2008 Dec; 20(12):2317-23. PubMed ID: 18804163
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3beta in the nucleus accumbens core mediates cocaine-induced behavioral sensitization.
Xu CM; Wang J; Wu P; Zhu WL; Li QQ; Xue YX; Zhai HF; Shi J; Lu L
J Neurochem; 2009 Dec; 111(6):1357-68. PubMed ID: 19799712
[TBL] [Abstract][Full Text] [Related]
12. [Effects of glycogen synthase kinase 3β overexpression in rat and glycogen synthase kinase 3β inhibitor SB-216763 on proliferation of hepatic oval cells].
Zhong JQ; Xie YK; Ji XK; Fu JH; Wang Y; Zhang QY; Shi HQ; Shan YF
Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):1003-6. PubMed ID: 23302485
[TBL] [Abstract][Full Text] [Related]
13. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells.
Zhang X; Yin WK; Shi XD; Li Y
Eur J Pharm Sci; 2011 Apr; 42(5):540-6. PubMed ID: 21352912
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
15. IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.
Wang WC; Kuo CY; Tzang BS; Chen HM; Kao SH
J Cell Biochem; 2012 Nov; 113(11):3567-75. PubMed ID: 22740511
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
18. Serine 9 and tyrosine 216 phosphorylation of GSK-3β differentially regulates autophagy in acquired cadmium resistance.
Park CH; Lee BH; Ahn SG; Yoon JH; Oh SH
Toxicol Sci; 2013 Oct; 135(2):380-9. PubMed ID: 23897984
[TBL] [Abstract][Full Text] [Related]
19. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
[TBL] [Abstract][Full Text] [Related]
20. Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer.
Chen S; Sun KX; Feng MX; Sang XB; Liu BL; Zhao Y
Drug Des Devel Ther; 2016; 10():1225-32. PubMed ID: 27051274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]